Synopsys, Inc. $SNPS Stock: Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Grows Position

Key Points

• Loring Wolcott & Coolidge Fiduciary Advisors increased its Synopsys stake by 0.7% in the third quarter to 353,913 shares valued at approximately $153.9 million. Institutional investors collectively own 85.47% of the company.
• Synopsys exceeded quarterly earnings and revenue expectations, reporting $3.91 in EPS and $2.48 billion in revenue, with revenue up 42.4% year over year. The board also authorized a $1 billion share buyback.
• Analyst sentiment remains broadly positive, with a consensus “Moderate Buy” rating and an average price target of $575, although insiders sold 117,163 shares worth about $51.4 million during the last quarter.

Loring Wolcott & Coolidge Fiduciary Advisors LLP MA lifted its position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 0.7% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 353,913 shares of the semiconductor company's stock after acquiring an additional 2,421 shares during the period. Synopsys accounts for 1.5% of Loring Wolcott & Coolidge Fiduciary Advisors LLP MA's holdings, making the stock its 21st largest position. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA owned about 0.18% of Synopsys worth $153,931,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in SNPS. Aries Wealth Management lifted its stake in shares of Synopsys by 14.1% in the third quarter. Aries Wealth Management now owns 932 shares of the semiconductor company's stock worth $405,000 after buying an additional 115 shares in the last quarter. Kingswood Wealth Advisors LLC boosted its position in Synopsys by 35.4% during the third quarter. Kingswood Wealth Advisors LLC now owns 1,225 shares of the semiconductor company's stock worth $533,000 after acquiring an additional 320 shares during the last quarter. Paladin Wealth LLC grew its stake in Synopsys by 22.7% during the 3rd quarter. Paladin Wealth LLC now owns 1,328 shares of the semiconductor company's stock valued at $578,000 after acquiring an additional 246 shares in the last quarter. Robeco Schweiz AG grew its stake in Synopsys by 40.5% during the 3rd quarter. Robeco Schweiz AG now owns 36,800 shares of the semiconductor company's stock valued at $16,006,000 after acquiring an additional 10,600 shares in the last quarter. Finally, Citizens Financial Group Inc. RI grew its stake in Synopsys by 39.2% during the 3rd quarter. Citizens Financial Group Inc. RI now owns 4,028 shares of the semiconductor company's stock valued at $1,752,000 after acquiring an additional 1,135 shares in the last quarter. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Synopsys Stock Performance

Shares of Synopsys stock opened at $430.14 on Monday. The firm has a market capitalization of $82.43 billion, a price-to-earnings ratio of 76.00, a PEG ratio of 1.75 and a beta of 1.21. Synopsys, Inc. has a fifty-two week low of $362.55 and a fifty-two week high of $539.48. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 1.34. The stock has a 50 day moving average of $430.32 and a 200 day moving average of $443.50.

Synopsys (NASDAQ:SNPS - Get Free Report) last posted its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.67 by $0.24. Synopsys had a return on equity of 6.24% and a net margin of 11.43%. The company had revenue of $2.48 billion during the quarter, compared to analysts' expectations of $2.44 billion. During the same quarter last year, the firm earned $3.39 earnings per share. The firm's quarterly revenue was up 42.4% compared to the same quarter last year. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. As a group, research analysts predict that Synopsys, Inc. will post 11.01 earnings per share for the current year.

Synopsys declared that its Board of Directors has authorized a stock buyback program on Monday, October 5th that authorizes the company to repurchase $1.00 billion in outstanding shares. This buyback authorization authorizes the semiconductor company to buy up to 1.1% of its shares through open market purchases. Share buyback programs are usually an indication that the company's board of directors believes its shares are undervalued.

Wall Street Analyst Weigh In

A number of analysts have commented on SNPS shares. Needham & Company LLC increased their price objective on shares of Synopsys from $580.00 to $620.00 and gave the company a "buy" rating in a report on Monday, October 12th. Roth Capital upgraded Synopsys to a "buy" rating in a report on Friday, September 25th. Morgan Stanley boosted their target price on Synopsys from $500.00 to $574.00 and gave the stock an "overweight" rating in a report on Tuesday, October 20th. Sanford C. Bernstein assumed coverage on Synopsys in a research report on Friday, September 25th. They issued an "outperform" rating for the company. Finally, HSBC cut Synopsys from a "buy" rating to a "reduce" rating in a report on Friday, September 25th. One research analyst has rated the stock with a Strong Buy rating, twenty-two have issued a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $575.00.

Insiders Place Their Bets

In related news, CEO Sassine Ghazi sold 14,604 shares of the firm's stock in a transaction dated Tuesday, September 15th. The stock was sold at an average price of $374.88, for a total transaction of $5,474,747.52. Following the completion of the sale, the chief executive officer directly owned 76,865 shares of the company's stock, valued at approximately $28,815,151.20. This trade represents a 15.97% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Aart de Geus sold 25,000 shares of the firm's stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $441.76, for a total value of $11,044,000.00. Following the sale, the insider directly owned 120,421 shares of the company's stock, valued at $53,197,180.96. The trade was a 17.19% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 117,163 shares of company stock valued at $51,366,457. 0.56% of the stock is owned by company insiders.

About Synopsys

Synopsys, Inc is an electronic design automation (EDA) and semiconductor intellectual property company serving the global semiconductor and electronics industries. Its software helps engineers design, verify, test and manufacture advanced integrated circuits and electronic systems.

The company's products and services support digital and analog design, functional verification, design-for-test, manufacturing and semiconductor engineering workflows. Synopsys also provides reusable semiconductor IP, including processor cores, interface technologies, security solutions and other components used in system-on-chip designs.

In addition to its semiconductor design offerings, Synopsys provides software development and application security tools intended to help organizations identify and manage vulnerabilities and risks across the software development lifecycle.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.